历史搜索:A549    293T 金黄色葡萄球菌 大肠杆菌 AKK菌
购物车 1 种商品 - 共0元
当前位置: 首页 > ATCC代理 > Escherichia coli (Migula) Castellani and Chalmers B161491
Escherichia coli (Migula) Castellani and Chalmers
Escherichia coli (Migula) Castellani and Chalmers
规格:
价格:
编号:B161491
品牌:Mingzhoubio

标准菌株
定量菌液
DNA
RNA

规格:
冻干粉
斜面
甘油
平板


加入购物车 在线咨询 收藏
产品名称
Escherichia coli (Migula) Castellani and Chalmers
商品货号
B161491
Reports
Upon your purchase of this product, you will receive a report containing MIC values, a susceptibility profile, and the DNA sequence information for predicted annotated antibiotic resistance genes and 16S rRNA genes. This report will be provided in multiple formats (.pdf, .txt, .xls, .zip).
Deposited As
Escherichia coli
培养基
Classification
Enterobacteriaceae, Escherichia
Strain Designations
1099705
Application
Drug discovery and development
Development of molecular-based detection assays
Development of updated sterility protocols
Isolation
Urine
Isolation Date
2014
Geographic Source
Czech Republic
Biosafety Level
2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format
frozen
Storage Conditions
-80°C or colder
Preceptrol®
no
Annotated Genes
AAC(3)-IIa
aadA5
acrA
acrB
acrD
acrE
acrF
APH(3'')-Ib
APH(6)-Id
baeR
CMY-47
CTX-M-14
emrB
emrE
macA
macB
marA
mdtB
mdtC
mdtF
mexB
msbA
TEM-1
tet(G)
tolC
Type Strain
no
MIC Range
Susceptible
Amikacin: ≤16 µg/mL
Ceftazidime: ≤4 µg/mL
Doripenem: ≤1 µg/mL
Fosfomycin: ≤64 µg/mL
Meropenem: ≤1 µg/mL


Intermediate
Amoxicillin-clavulanate: 16/8 µg/mL
Aztreonam: 8 µg/mL
Piperacillin-tazobactam: 32/4 - 64/4 µg/mL


Resistant
Cefepime: ≥16 µg/mL
Ceftriaxone: ≥4 µg/mL
Ciprofloxacin: ≥4 µg/mL
Imipenem: ≤1 µg/mL
Levofloxacin: ≥8 µg/mL
Tetracycline: ≥16 µg/mL
Trimethoprim-sulfamethoxazole: ≥4/76 µg/mL


Comments
This strain is part of the Global Priority Superbugs collection. It is an extensively characterized antimicrobial-resistant clinical isolate with validated genotypic and phenotypic activity against a variety of drug classes. This strain is provided with geographic source information; an NGS-assembled whole genome sequence, including annotated antibiotic resistance and rRNA genes; and an expanded level of susceptibility data with MIC test results.

Minimum inhibitory concentration (MIC) ranges for resistant, intermediate, and susceptible are based on criteria within the Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition.

Predicted antimicrobial resistance gene sequence data are provided for informational purposes only and are based on open reading frames (ORFs) identified and annotated from contigs produced during next-generation sequencing (NGS). ATCC does not warrant that the entire predicted antimicrobial resistance gene is present within the sequence prepared for lot-specific reports. Likewise, the information provided merely indicates that some portion of the sequence (whole or in part) is present based on analytical base pair alignment with known gene sequences.
Medium
ATCC® Medium 18: Trypticase Soy Agar/Broth
Growth Conditions
Temperature: 37°C
Atmosphere: Aerobic
Name of Depositor
International Health Management Associates (IHMA), Inc.
Special Collection
Global Priority Superbugs
Chain of Custody
ATCC <-- International Health Management Associates (IHMA), Inc.
Patient Age
78
Patient Gender
Female
References

Clinical and Laboratory Standards Institute (CLSI). Performance Standards for Antimicrobial Susceptibility Testing, 26th Edition. Wayne, PA. M100S, 2016.

  • 王经理
    手机号：17280875617
    QQ：1438578920
  • 胡经理
    手机号：13345964880
    QQ：2438244627
  • 周经理
    手机号：17757487661
    QQ：1296385441
  • 于经理
    手机号：18067160830
    QQ：2088210172
  • 沈经理
    手机号：19548299266
    QQ：2662369050
  • 李经理
    手机号：13626845108
    QQ：972239479